JUSTIN SISK: Open Payments
NPI 1598285819 · TUSCALOOSA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$802 in 61 payments from 12 companies in 2025. Trend: 2023 $927 · 2024 $1,281 · 2025 $802
Food & beverage: $802
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 33 | $263 |
| Novo Nordisk Inc | 8 | $169 |
| Actelion Pharmaceuticals US, Inc. | 5 | $99 |
| Merck Sharp & Dohme LLC | 4 | $68 |
| PFIZER INC. | 3 | $54 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $35 |
| United Therapeutics Corporation | 1 | $25 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $24 |
| E.R. Squibb & Sons, L.L.C. | 1 | $21 |
| Amgen Inc. | 1 | $16 |
Products named: LEQVIO, Wegovy, UPTRAVI, VERQUVO, VYNDAQEL, JARDIANCE, Tyvaso, Kerendia.
Industry payments across AL — which companies pay providers there.
